Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Shares Issued: 2019-2024

Historic Shares Issued for Foghorn Therapeutics (FHTX) over the last 6 years, with Dec 2024 value amounting to $103.4 million.

  • Foghorn Therapeutics' Shares Issued was N/A to $49,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $102.7 million, marking a year-over-year change of. This contributed to the annual value of $103.4 million for FY2024, which is 5715.58% up from last year.
  • Foghorn Therapeutics' Shares Issued amounted to $103.4 million in FY2024, which was up 5,715.58% from $1.8 million recorded in FY2023.
  • Foghorn Therapeutics' 5-year Shares Issued high stood at $122.1 million for FY2020, and its period low was $1.8 million during FY2022.
  • Its 3-year average for Shares Issued is $35.6 million, with a median of $1.8 million in 2023.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 17,573.08% in 2020, then slumped by 95.82% in 2022.
  • Yearly analysis of 5 years shows Foghorn Therapeutics' Shares Issued stood at $122.1 million in 2020, then plummeted by 65.44% to $42.2 million in 2021, then plummeted by 95.82% to $1.8 million in 2022, then increased by 0.85% to $1.8 million in 2023, then soared by 5,715.58% to $103.4 million in 2024.